Inotropic, chronotropic, and dromotropic effects mediated via parasympathetic ganglia in the dog heart.
Some parasympathetic ganglionic cells are located in the epicardial fat pad between the medial superior vena cava and the aortic root (SVC-Ao fat pad) of the dog. We investigated whether the ganglionic cells in the SVC-Ao fat pad control the right atrial contractile force, sinus cycle length (SCL), and atrioventricular (AV) conduction in the autonomically decentralized heart of the anesthetized dog. Stimulation of both sides of the cervical vagal complexes (CVS) decreased right atrial contractile force, increased SCL, and prolonged AV interval. Stimulation of the rate-related parasympathetic nerves to the sinoatrial (SA) node (SAPS) increased SCL and decreased atrial contractile force. Stimulation of the AV conduction-related parasympathetic nerves to the AV node prolonged AV interval. Trimethaphan, a ganglionic nicotinic receptor blocker, injected into the SVC-Ao fat pad attenuated the negative inotropic, chronotropic, and dromotropic responses to CVS by 33 approximately 37%. On the other hand, lidocaine, a sodium channel blocker, injected into the SVC-Ao fat pad almost totally inhibited the inotropic and chronotropic responses to CVS and partly inhibited the dromotropic one. Lidocaine or trimethaphan injected into the SAPS locus abolished the inotropic responses to SAPS, but it partly attenuated those to CVS, although these treatments abolished the chronotropic responses to SAPS or CVS. These results suggest that parasympathetic ganglionic cells in the SVC-Ao fat pad, differing from those in SA and AV fat pads, nonselectively control the atrial contractile force, SCL, and AV conduction partially in the dog heart.
Tsuboi
M
M
Department of Pharmacology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Furukawa
Y
Y
Nakajima
K
K
Kurogouchi
F
F
Chiba
S
S
D000818:Animals; D016280:Atrial Function, Right / Q000187:drug effects / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004558:Electric Stimulation; D005726:Ganglia, Parasympathetic / Q000187:drug effects / Q000502:physiology*; D005730:Ganglionic Blockers / Q000008:administration & dosage; D006321:Heart / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D007267:Injections; D008012:Lidocaine / Q000008:administration & dosage; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D010496:Pericardium / Q000294:innervation; D011930:Reaction Time / Q000187:drug effects; D012849:Sinoatrial Node / Q000187:drug effects / Q000294:innervation; D026941:Sodium Channel Blockers; D013268:Stimulation, Chemical; D014294:Trimethaphan / Q000008:administration & dosage; D014630:Vagus Nerve / Q000502:physiology; D014683:Vena Cava, Superior / Q000294:innervation
D005730:Ganglionic Blockers; D026941:Sodium Channel Blockers; D014294:Trimethaphan; D008012:Lidocaine